CRISPR Therapeutics AG Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (22)

Latest Posts

About This Stock More About This Stock
How Subtle Chart Patterns Can Lead To Explosive Rallies
Article By: Deron Wagner
Tuesday, December 24, 2019 7:10 AM EDT
Stock traders who focus on trading only the most obvious chart patterns are missing out on huge gains that more subtle patterns can provide.
In this article: CRSP
Read
Biotech Scoreboard, November: Gene Therapy Stocks Gain Momentum
Article By: Rod Raynovich
Saturday, November 30, 2019 11:38 PM EDT
IBB is up 11.2% for November, XBI up 6.3%, but NASDAQ-100 (QQQ) leads up 14.5 %. The big winners for the month include NTLA up 47.24%.
In this article: IBB, QQQ, XBI, SRPT, NTLA, CRSP
Read
Crispr Therapeutics Trade Review: How We Scored A Huge 24% Gain In Just 2 Days
Article By: Deron Wagner
Thursday, November 21, 2019 12:25 PM EDT
We recently locked in a cool gain of +24% with a 2-day swing trade in Crispr Therapeutics (CRSP). Continue reading this educational trade walk-through to find out exactly how we did it.
In this article: CRSP
Read
Stock Charts To Watch - Monday, November 18
Video By: Harry Boxer
Monday, November 18, 2019 11:00 AM EDT
Advanced Micro Devices, Inc. hit one penny off my 40-dollar target on Monday.
In this video: AMD, OESX, INMD, SEAC, CLVS, COLL, CRSP, MAXR
Watch
Crispr Therapeutics Price Target Raised To $100 From $75 At Piper Jaffray
Article By: The Fly
Friday, June 7, 2019 5:52 AM EDT
Crispr Therapeutics and Vertex expanded their alliance to develop gene editing medicines to treat Duchenne muscular dystrophy and myotonic dystrophy type 1 with Crispr receiving $175M in cash up front.
In this article: CRSP Also: VRTX
Read

PARTNER HEADLINES

Latest Tweets for $CRSP

No tweets yet!